Latest

SARS-CoV-2

Featured Neuroscience Open Neuroscience Articles

·April 29, 2020·4 min read

COVID-19 study shows that men have over double the death rate of women

Males who contract COVID-19 have 2.5 times the death rate of women. Being males is a significant risk factor for worse disease severity, regardless of age. Researchers found a similar trend in data from the 2003 SARS outbreak. The study speculates the reason why males are more prone to negative outcomes of coronavirus is due to levels of ACE2, which is significantly higher in males than females.

Featured Neuroscience Psychology

·April 29, 2020·5 min read

How could Covid-19 and the body’s immune response affect the brain?

Mounting evidence suggests coronavirus affects the brain, in addition to the lungs. Researchers are examining the threat COVID-19 posses to long term brain health. They speculate maternal inflammation could lead to an increased risk of autism-like behaviors and neurodevelopment deficits in children born to mothers diagnosed with coronavirus. Other studies are exploring how the virus may spread in the nervous system via synaptic transmission.

Featured Neurology Neuroscience

·April 28, 2020·5 min read

Seniors with COVID-19 show unusual symptoms

Confusion, delirium, and disorientation may be additional symptoms older adults with coronavirus face. Researchers report changes in the central nervous system are driving these new symptoms of COVID-19.

Featured Neuroscience

·April 28, 2020·4 min read

COVID-19: Study recommends social distancing stay in place until summer

Despite the push for the country to reopen, researchers warn social distancing measures should remain in effect until the summer to avoid a potential deadly resurgence of coronavirus. A new model shows that as more emphasis is placed on relaxing social distancing, a resurgence of COVID-19 infections becomes more likely and will be more difficult to control later in the year.

This shows a woman in a facemask smelling a flower

Featured Neuroscience

·April 27, 2020·5 min read

Loss of smell associated with milder clinical course and less hospitalizations in COVID-19

COVID-19 patients who reported smell loss as a symptom of their infection are ten times less likely to be hospitalized for coronavirus than those who do not report anosmia.

Featured Neuroscience Open Neuroscience Articles

·April 27, 2020·4 min read

Patterns of common coronavirus infections could aid understanding of COVID-19

Examining different types of coronaviruses, researchers report the viral infections coexist in most winter seasons, although they exhibit structured seasonal patterns with some appearing to generate illnesses in the community at the same time. Others appear to circulate in their own unique patterns. Findings suggest SARS-CoV-2, the virus responsible for COVID-19, may find itself in competition with other seasonal coronaviruses and either struggle to persist in the longterm or may eliminate one or more seasonal coronavirus.

Featured Neuroscience Open Neuroscience Articles

·April 27, 2020·2 min read

COVID-19 and pregnancies: What we know

COVID-19 poses a substantial and underappreciated risk to pregnant women, researchers warn. Some studies suggest the novel coronavirus can be transmitted to the fetus in utero. Researchers impress more research be conducted into the effects of COVID-19 infection during pregnancy and the risks it poses postnatally.

This shows a woman looking out of a window

Featured Neuroscience Psychology

·April 26, 2020·3 min read

COVID-19: The downside of social distancing

Social distancing, while essential for public health during the coronavirus pandemic, thwarts the human impulse to draw together in times of danger.

Featured Neuroscience Open Neuroscience Articles

·April 25, 2020·3 min read

Novel Compounds Designed To Inhibit SARS-CoV-2 Main Protease

Researchers have developed two new compounds that are able to inhibit SARS-CoV-2 main protease. The study reports one of the compounds is a strong drug candidate for further investigative trials in the treatment of coronavirus.

Featured Neuroscience

·April 25, 2020·2 min read

Higher levels of destructive white blood cells associated with more severe COVID-19

Patients with severe COVID-19 infections have higher blood levels of neutrophil extracellular traps (NETs), which produce NETosis, an inflammatory type of neutrophil cell death. Researchers believe the NETs may be relevant to numerous aspects of novel coronavirus as thrombosis and inflammation are hallmarks of the severe infection.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 24, 2020·4 min read

Highlighting diabetes risks in COVID-19

The risk of severe complications, including death, from coronavirus, is almost 50% higher in those with diabetes than the general population. Although it is yet to be verified in humans, new findings suggest diabetes may not only be a risk factor for severe COVID-19, but the infection could result in causing new onset of diabetes due to the damage it causes to pancreatic beta cells.

Featured Genetics Neuroscience

·April 24, 2020·3 min read

Asthma drug in clinical trial to treat severe COVID-19 patients

A new clinical trial is underway to test ibudilast, an asthma drug approved in Japan, for the treatment of severe COVID-19. Ibudilast is a MIF inhibitor. MIF is a gene that regulates immune response and is a driver of inflammation which results in the cytokine storm associated with coronavirus.